Blood Testing Market, By Test Type (Clinical Chemistry (Basic/Lipid Metabolic Panels, Electrolyte Panel, Liver Function Tests, Renal Function Tests, Thyroid Function Tests, Blood Glucose Tests), Hematology and Coagulation, Complete Blood Count (CBC), Platelet Count and Function Tests, Prothrombin Time (PT) / International Normalized Ratio (INR), Activated Partial Thromboplastin Time (aPTT), Immunoassay and Serology, Infectious Disease Testing (HIV, Hepatitis, COVID-19, STIs), Autoimmune Disease Testing, Allergy Testing, Cancer Biomarker Tests, Hormone Level Testing, Molecular Blood Tests, Nucleic Acid Testing (NAT) for Infectious Diseases, Pharmacogenomics, Oncology (Liquid Biopsy), Microbiology, Blood Culture Tests, Gram Stains, Others), By Technology (Immunoassay, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Clinical Chemistry Analysis, Hematology Analyzers, Mass Spectrometry, and Flow Cytometry), By Product (Reagents and Kits, Instruments and Analyzers, Consumables (tubes, slides, etc.), and Software and Services), By Application (Disease Diagnosis, Wellness and Health Monitoring, Therapeutic Drug Monitoring, Pre-Natal Screening, Pre-Operative Testing, and Drug of Abuse Testing), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Research Institutes and Academia, and Home Care and Self-Testing Users), By Sample Type (Whole Blood, Serum, and Plasma), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)